Trials / Unknown
UnknownNCT05817643
Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers
A Randomized, Open-label, 2-period, Crossover, Pilot Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Allyx Therapeutics · Industry
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This project is developing a novel disease-modifying compound for Alzheimer's disease (AD).
Detailed description
The primary objective of this study is to evaluate for an effect of food consumption on the pharmacokinetics profile of BMS984923. Safety and tolerability is also assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-984923 | Oral capsule |
Timeline
- Start date
- 2023-01-10
- Primary completion
- 2023-02-27
- Completion
- 2024-11-15
- First posted
- 2023-04-18
- Last updated
- 2024-07-30
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05817643. Inclusion in this directory is not an endorsement.